. 2016 Jan 6;12(1):e1005372. doi: 10.1371/journal.ppat.1005372

Table 1. Expression of TIGIT and PD-1 on ATL cells and HTLV-1 infected CD4+ T cells.^* .

Disease Type	TIGIT^- PD1^-	TIGIT⁺ PD1^-	TIGIT^- PD1⁺	TIGIT⁺ PD1⁺
ATL #1 ^(c)	0.06	0.61	1.91	97.4
ATL #2 ^(c)	7.38	4.38	19.6	68.6
ATL #3 ^(c)	0.31	21.3	0.15	78.3
ATL #4 ^(a)	51.2	39.8	2.66	6.38
ATL #5 ^(a)	2.69	1.76	1.76	93.8
HAM/TSP #1	17.8	18.9	12.0	51.3
HAM/TSP #2	34.5	30.2	14.3	21.1
HAM/TSP #3	13.2	19.9	15.6	51.2
HAM/TSP #4	18.1	13.6	12.6	55.7
HAM/TSP #5	20.8	24.1	11.9	43.2
Healthy donors	75.3 ± 8.91	3.09 ± 1.05	13.8 ± 3.73	7.89 ± 4.44

*For acute ATL cases, the numbers indicate the percentage of CD3^lowCD4⁺ ATL cells in each category. For HAM/TSP cases, the numbers indicate the percentage of CD4⁺CADM1⁺ T cells. In healthy donors, the numbers indicate the percentage of CD4⁺ T cells. The mean percentages (± SD) from 4 donors are shown for healthy donors.

(a): acute ATL,

(c): chronic ATL.

Table 1. Expression of TIGIT and PD-1 on ATL cells and HTLV-1 infected CD4+ T cells.* .

Table 1. Expression of TIGIT and PD-1 on ATL cells and HTLV-1 infected CD4+ T cells.^* .